You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XFOR Sale Disclosure
Kirske David · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$36.43K
Kirske David Chief Financial Officer
XFOR
X4 Pharmaceuticals
XFOR
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
XFOR daily price context
Close on/before transaction
$4.67
Jun 30, 2026
First close after public filing
$4.13
Jul 2, 2026
30-day return after filing
-3.63%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,543 shares @ $4.26
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001501697-26-000065
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$36.43K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| X4 Pharmaceuticals, Inc XFOR Current | Sale | Jun 30, 2026 | $36.43K |